Qualigen Therapeutics Inc. Made Headway
Qualigen Therapeutics Inc. (QLGN:NASDAQ) shot up at $0.93, representing a gain of 53.6%. On Mon, Apr 11, 2022, QLGN:NASDAQ touched a New 2-Week Intraday Low of $0.58. The stock got featured on our News Catalysts scanner on Tue, Apr 12, 2022 at 11:20 AM in the 'BIOTECH' category. From Mon, Mar 28, 2022, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Nov 23, 2021 at $3.12 with a volume of 219M+, and its share price has been moving sideways in recent weeks.
About Qualigen Therapeutics Inc. (QLGN:NASDAQ)
Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using...
Top 10 Gainers:
- PolarityTE, Inc. (PTE:NASDAQ), 82.97%
- Histogen Inc. (HSTO:NASDAQ), 67.78%
- Qualigen Therapeutics Inc. (QLGN:NASDAQ), 53.62%
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 47.18%
- TROOPS Inc. (TROO:NASDAQ), 31.29%
- Vertical Aerospace Ltd. (EVTL:NYSE), 30.93%
- MiNK Therapeutics Inc. (INKT:NASDAQ), 28.74%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 24.01%
- Aterian Inc. (ATER:NASDAQ), 23.76%
- Poema Global Holdings Corp. (PPGH:NASDAQ), 23.69%